AMEREN CORP (AEE): what the price assumes

boothcheck covers AMEREN CORP (AEE) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Exported: 2026-08-31 · Source: https://boothcheck.com/report/AEE

Headline

FieldValue
TickerAEE
CompanyAMEREN CORP
Sector / IndustryUtilities
Current price$106.12/sh
CompositionElectric - Residential 38% / Electric - Commercial 25% / Electric - Industrial 6% / Electric - Other 18% / Natural gas - Residential 9% / Natural gas - Commercial 3% / Natural gas - Industrial 0% / Natural gas - Other 1%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Multiple paid24x operating income

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 6% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-1.13σ
cohort percentile (of 70 peers)74

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.56x5expensive
Earnings1.73x3expensive
Relative0.70x2justifies
Growth1.25x2expensive

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.8%); the inversion above states its own rate.

Per-Model Detail (n=12)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthnoReference only (OCF-based, capex excluded): OCF $3.3B
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelativenoP/E 20x (static sector reference · 2026-04), scenarios: 16.7x / 20.0x / 23.3x (bear / base = reference held flat / bull), EV/EBITDA 15.99x
Simple DDMGrowthno
Two-Stage DDMGrowth$105.551.01xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$61.231.73xyesBV/sh $49.44, ROE (TTM) 11.5%, ke 9.3%
Two-Stage Excess ReturnAsset$67.841.56xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$71.121.49xyesRev $8.7B, growth 3% (input: historical growth; tapered), Terminal P/S: 2.8x / 3.4x / 3.9x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$126.700.84xyesEPS $5.68, growth 22% (input: historical EPS growth), PEG=0.84 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$13.727.73xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.67B × (1−14%) / WACC 5.8% → EPV (no growth)
Residual IncomeAsset$69.141.53xyesBV $49.44 + 5yr PV of (ROE (TTM) 11.5% − Kₑ 9.3%) × BV; BV grows 7.4%/yr
Graham NumberAsset$79.491.34xyes√(22.5 × EPS $5.68 × BVPS $49.44) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $2.18B × sector EV/EBITDA 13.0x
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$183.270.58xyesEPS $5.68 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$9.8110.82xyesBV $49.44 × (ROIC 1.2% / WACC 5.8%)
P/Sales SectorRelativenoRevenue $8.75B × sector P/S 2.5x
PEG Fair ValueRelative$190.050.56xyesEPS $5.68 × (PEG 1.5 × growth 22.3% (input: historical EPS growth)) → PE 33.5x
Earnings YieldEarnings$61.411.73xyesEPS $5.68 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Ameren Missourioperatingenterprise$4.8b$910.0m operating-incomewithheldunresolved no unit value
Ameren Illinois Electric Distributionoperatingenterprise$2.4b$347.0m operating-incomewithheldunresolved no unit value
Ameren Illinois Natural Gasoperatingenterprise$968.0m$242.0m operating-incomewithheldunresolved no unit value
Ameren Transmissionoperatingenterprise$675.0m$580.0m operating-incomewithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$21.8b
Net debt / NOPAT (after-tax)11.66x
Net debt / operating income (pre-tax)10.02x
Interest coverage2.6x
Share count CAGR (dilution)1.8%
Burning cashno

Bullet Takeaways

Bull Case

Only one group of methods reaches today's share price, and which group it is tells you what kind of company this is. The forward cash-flow methods land close, with the price about 11% above them. Everything anchored on what exists today sits well underneath: the price stands about 29% above the peer multiple methods, about 74% above the asset value methods, and about 89% above the earnings power methods. For most businesses that spread would be a warning. For a regulated utility it describes the accounting rather than the risk, because a utility's earnings do not come from selling more of something at a better margin. They come from putting capital into the ground and being allowed to earn a return on it. A method that values the rate base as it stands is answering a question about the past.

What is coming into the ground is unusually visible. The FY2025 10-K records that in February 2026 Ameren Missouri signed electric service agreements with large load customers "representing 2.2 gigawatts of demand. Construction agreements have been signed with developers representing 3.4 gigawatts of demand, which includes the executed electric service agreements." These are contracts, not projections. And the terms attached to them were tightened first: in November 2025 the Missouri commission approved a change to the large primary service tariff requiring customers asking for 75 megawatts or more at transmission voltage to accept additional terms, including "a service term of 12 years plus a ramp period". A twelve-year commitment from a data-centre developer is what turns a demand forecast into a financeable asset.

The regulatory machinery has been moving in the same direction. Ameren states that it works to advocate policies and "enhancing our regulatory frameworks is important to drive investment in our business segments, earn competitive returns on those investments, and realize timely recovery of our costs". In Illinois the mechanics are becoming formulaic: from 2027 the return component used in the distribution formula will be the commission-approved figure for that year, and returns on energy-efficiency investment can move up or down by as much as 200 basis points depending on whether savings targets are hit. Predictable rules are worth more to an owner of capital-intensive assets than a generous one-off decision.

Operationally the business sits comfortably in the middle of a large, well-documented peer set. Ameren converts 23.9% of revenue into operating profit on about $8.88B of sales. Duke (DUK) converts 27.2% on $33.17B, Evergy (EVRG) 25.9% on $6.03B, American Electric Power (AEP) 24.2% on $22.26B, and at the other end Xcel (XEL) 18.0% on $14.78B and Consolidated Edison (ED) 17.2% on $17.39B. Nothing here distinguishes Ameren as an operator, and it does not have to. Return on equity runs about 11.3% against book value of roughly $48.69 a share, which is the arithmetic of a regulated business earning close to its allowed return.

The funding model is the part that looks alarming and is not, provided one condition holds. The share count has grown about 1.8% a year over the four years to March 2026, and borrowings are heavy. That is how rate base gets financed, and the dilution is only destructive if the capital raised earns less than it costs. On the evidence of the returns being allowed and the demand now under contract, it currently earns more.

Bear Case

Here is the part a holder would rather not sit with. Almost nothing about owning these shares at $113.77 depends on how well Ameren runs a power system. The price capitalises company-wide operating income at about 24 times, and that multiple survives even if operating profit slips roughly 2.8% a year over the next several years, which sounds forgiving until you see what makes it forgiving: the whole calculation is discounted at a cost of capital near 6.2%. Move that number by a single percentage point and the tolerable trajectory swings by roughly 9.6 points of annual profit growth. This is a position in the rate environment wearing a utility's clothes.

Leverage sharpens the same exposure. Borrowings run close to 9.7 times a single year's operating profit, and that profit covers interest about 2.8 times. Those are ordinary numbers for a regulated utility and they are also the reason the rate environment is not an abstraction here. Higher rates raise the cost of the next bond and lower the value of the cash the existing assets produce, at the same time. Ameren's own first-quarter results already flagged higher interest expense as an offset to the earnings its infrastructure investment produced.

The allowed return, which is the entire engine of the bull case, is currently being argued in court. The 10-K discloses that "Ameren Illinois has filed an appeal of the ICC-determined ROE for 2024 through 2027 to the Illinois Appellate Court for the Fifth Judicial District." A company appealing the return it is permitted to earn on four years of investment is a company telling you that the regulator set it lower than the company thinks it deserves. Meanwhile the mechanics of recovery are slow by design. The filing defines the exposure as "Regulatory lag - The exposure to differences in costs incurred and actual sales volumes as compared with the associated amounts included in customer rates" and notes that rate increase requests in traditional reviews "can take up to 11 months to be acted upon by the MoPSC and the ICC". Costs move immediately; recovery does not.

The demand story is also not a signed cheque. Alongside the 2.2 gigawatts of executed agreements, the risk factors carry the qualifier directly: "The Ameren Companies may or may not experience the energy demand growth currently being forecasted depending on the decisions of potential new customers". Building generation and transmission for load that arrives late is the classic way a utility ends up with an asset the commission is reluctant to let it earn on, and the same risk section lists managing the impact on customer rates and the possibility that future data-centre demand may not be realised at the projected pace.

Against the peer set the multiple looks generous rather than earned. It sits at the very top of the peer distribution, well past the upper quartile, for a business whose operating conversion of 23.9% ranks in the middle. Edison International (EIX) converts 30.8% on $19.61B and grew 13.1%; WEC (WEC) converts 22.7% on $10.08B while growing 11.2%; Alliant (LNT) 23.0% on $4.42B growing 8.3%. Several of those are growing faster than Ameren on the revenue line and none of them is being priced this way.

The bull answer, that regulated utilities compound by adding rate base and that the contracts now signed make that addition visible, is a real argument and it is why the price is where it is. The bear response is narrower and harder to dismiss: that argument was equally true a year ago and two years ago, and what actually changed the value of the shares was the discount rate applied to it. Buying a regulated asset at the top of its cohort's valuation range is a bet that the rate applied stays where it is. Nothing in the operating business influences that.

Valuation

What $113.77 assumes is easier to state than to evaluate. The market capitalises company-wide operating income at roughly 24 times, and the price implies operating profit can decline about 2.8% a year through a five-year stage and still be supported. Settling thereafter at a 4% long-run pace is the tail assumption. A valuation that tolerates shrinkage is not usually described as demanding. The reason it can tolerate it is a cost of capital near 6.2%, low because the earnings stream is regulated and the equity moves less than the market does. Almost all of the work in this valuation is being done by that rate rather than by anything Ameren does.

The sensitivity is the number worth carrying away. Each additional percentage point of required return moves the profit trajectory the price can support by around 9.6 points. Few businesses are that geared to a single input. It is the mathematical statement of what a long-duration, heavily financed asset is.

The methods sort in the pattern that regulated utilities always produce, and it is worth reading rather than averaging. Of the four groups, the forward cash-flow methods are nearest, with the price about 11% above them. Beyond that the distances widen: the price sits about 29% above where the peer multiple methods land, about 74% above the asset value methods, and about 89% above the earnings power methods. One of that last group is instructive rather than dismissible. It averages operating profit over five years, adds back one-time charges, taxes the result and capitalises it with no growth at all, then nets off what the company owes. For a business financed the way this one is, that arithmetic leaves very little. It is not a verdict on the company. It is a measurement of how much of the equity value depends on the assets Ameren has not built yet, and the answer is most of it.

Three filing-reported inputs sit under the growth half of that calculation. The first is contracted demand: agreements "representing 2.2 gigawatts of demand", with construction agreements covering more. The second is the speed of recovery, which the filing defines plainly, noting that rate increase requests in traditional regulatory rate reviews "can take up to 11 months to be acted upon by the MoPSC and the ICC". The third is the allowed return itself, which for Illinois distribution service becomes a formula tied to the commission's annual determination from 2027, with efficiency-linked adjustments of up to 200 basis points either way. Revenue growth in this business is not sold. It is authorised.

Cohort position is the least comfortable part. Ameren converts 23.9% of about $8.88B of revenue into operating profit, which places it around the middle of a well-populated group. Southern (SO) converts 24.2% on $30.18B, PPL (PPL) 23.3% on $9.41B, Pinnacle West (PNW) 20.9% on $5.46B, Portland General (POR) 14.0% on $3.52B. What separates Ameren is not the conversion but the multiple, which sits at the very top of that distribution, beyond the upper quartile.

Solvency does not endanger the business and it does shape the outcome. Borrowings sit close to 9.7 times a year's operating profit, that profit covers interest about 2.8 times, and the share count has grown about 1.8% a year over the four years to March 2026 as new capital was raised to fund construction. None of that is unusual for a regulated utility, and all of it means the equity is the thin slice on top of a large financed asset. That is precisely why the discount rate, rather than the demand forecast, is the variable a holder should watch.

Catalysts

Second-quarter results are presented on the morning of Friday, July 31, 2026. For a regulated utility the release itself rarely surprises; what matters is whether the annual range is left alone.

The first quarter set that range's credibility. Diluted earnings per share came to $1.28 against $1.07 a year earlier, with net income attributable to common shareholders of $357 million versus $289 million. The company attributed the improvement to earnings on infrastructure investment made to improve reliability and service quality, partly offset by lower Ameren Missouri electric retail sales on a warmer than normal winter and by higher interest expense. Ameren reaffirmed full-year 2026 guidance of $5.25 to $5.45 per diluted share at the same time.

Two forward markers frame the rest of the year. Management has issued a compound annual earnings growth target of 6% to 8% for 2026 through 2030, measured from the midpoint of the 2026 range. That target is what the current multiple is being paid against, so any commentary that moves it matters more than a quarterly beat. The second marker is regulatory. The appeal Ameren Illinois has filed over the commission-determined return on equity for 2024 through 2027 is unresolved, and the large-load service agreements signed in February 2026 have to convert into construction, connection and rate base on schedule. Neither of those is a July event, but both are the substance behind the growth target the July call will reaffirm or qualify.

Peer Cohorts (Per Segment, With Filing Citations)

Ameren Missouri (reported)

Ameren Illinois Electric Distribution (reported)

Ameren Illinois Natural Gas (reported)

Ameren Transmission (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Ameren second quarter 2026 earnings webcast announcement, July 9, 2026; Ameren first quarter 2026 results, May 5, 2026 · Ameren first quarter 2026 results, May 5, 2026 · Ameren second quarter 2026 earnings webcast announcement, July 9, 2026 · Ameren 2025 results and long-term growth guidance, February 2026

View the full interactive AEE report on boothcheck